Welcome to our Independent Ethics Committee (IEC), constituted in accordance with the guidelines of the Central Drugs Standard Control Organization (CDSCO) and the provisions of Schedule Y of the Drugs and Cosmetics Rules, 1945.
Our IEC is dedicated to safeguarding the rights, safety, dignity, and well-being of research participants involved in clinical trials and biomedical research. The committee independently reviews, approves, and monitors research proposals to ensure that ethical standards and regulatory requirements are upheld consistently.
Committed to transparency, scientific integrity, and ethical rigor, our IEC operates as a multidisciplinary body comprising qualified medical, scientific, legal, and lay representatives. We strive to promote responsible research practices in alignment with national regulations and internationally accepted ethical principles such as those outlined in the Declaration of Helsinki, ICH-GCP Guidelines, and NDCT Rules, 2019.
For more information on our review processes, submission requirements, and policies, please contact us or explore our website further.
Key Features & Benefits:
- Regulatory Compliance under CDSCO, Schedule Y, NDCT Rules, and ICH-GCP.
- Multidisciplinary Expert Committee with medical, scientific, legal, and lay members.
- Strong focus on participant rights, safety, and well-being.
- Transparent and documented review and approval process.
- Ongoing oversight and monitoring of approved research studies.
Quick Contact
Have questions about this service or need a custom quote? Reach out to our experts today!
- +91 8670033134
- info@absclinicalsolutions.com
- Mon - Fri: 9:30 AM - 6:00 PM IST